Clik here to view.
National Cancer Prevention Month
“Our best treatment for Esophageal Cancer is preventing Esophageal Cancer.” ~ Dr. John C. Lipham, M.D. Chair, ECAN Board of Directors Click here to see Dr. Lipham’s message A message from ECAN’s...
View ArticleClik here to view.
Powerful Tool to Catch Esophageal Cancer Before It Starts
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening tool for Barrett’s Esophagus and Esophageal Adenocarcinoma. The study included 124...
View ArticleClik here to view.
A Message from our Founder
March 27, 2024 marks 16 years since my extraordinary husband Monte Mordecai took his last breath on earth. I’m still filled with gratitude for Monte and my good fortune to have had such a loving,...
View ArticleApril is Esophageal Cancer Awareness Month
ECAN started Esophageal Cancer Awareness Month 15 years ago and we have been delighted to see how many companies, organizations, and individuals have taken advantage of this important opportunity to...
View ArticleClik here to view.
Funding Available for Esophageal Cancer Prevention & Treatment Research
Millions are available for research into the prevention, detection, diagnosis, treatment, and survival of Esophageal Cancer through the Department of Defense Peer Reviewed Cancer Research Program....
View ArticleTake Your Passion to End Esophageal Cancer to Capitol Hill
DEADLINE FAST APPROACHING! Join ECAN on Capitol Hill in June as we advocate to end Esophageal Cancer with our elected officials during ECAN’s first in-person Hill Day. The registration deadline to join...
View ArticleClik here to view.
A Father’s Day Challenge: Raise $5,000 and every dollar will be matched
This day is meant to honor those special men who have made a significant difference in our lives. Now, a generous donor is making it possible for you to honor that man in your life with a truly...
View ArticleFDA Advisory Panel votes to limit some EC patients’ access to immunotherapy
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with advanced Gastroesophageal Cancer, Esophageal...
View ArticleStudy finds Regimen that doesn’t include Radiation is Better than current...
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated with perioperative chemotherapy when compared with chemoradiation. The phase 3...
View ArticleClik here to view.
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE...
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* negative Esophageal Cancer found at the junction of the stomach and...
View Article